Kura Oncology (KURA) Reports In-Line Q4 EPS

Kura Oncology (NASDAQ: KURA) reported Q4 EPS of ($0.55), in-line with the analyst estimate of ($0.55).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• GLJ Research on Sell Rated Tesla (TSLA): 'We now see FSD as the main reason TSLA’s stock will bleed lower this year'
• Raymond James sees positive earnings trends across market caps